---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000458142.md"
description: "Fate Therapeutics presented updated clinical data at ACR Convergence 2025 showing immune system remodeling and durable responses in patients with systemic lupus erythematosus (SLE) treated with its off-the-shelf FT819 CAR-T cell therapy. This suggests potential benefit in a difficult-to-treat autoimmune condition. $Fate Therap(FATE.US)"
datetime: "2026-02-07T17:18:21.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000458142.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000458142.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000458142.md)
author: "[mkjh](https://longbridge.com/en/profiles/25461045.md)"
generator: "portal-rs"
---

# Fate Therapeutics presented updated clinical data …


### Related Stocks

- [FATE.US](https://longbridge.com/en/quote/FATE.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**